Update on the treatment of tuberculosis and latent tuberculosis infection
- PMID: 15941808
- DOI: 10.1001/jama.293.22.2776
Update on the treatment of tuberculosis and latent tuberculosis infection
Erratum in
- JAMA. 2005 Jul 13;294(2): 182. Dosage error in article text
Abstract
Tuberculosis (TB) has emerged as a global public health epidemic. Despite decreasing numbers of cases in the United States since 1992, TB remains a serious public health problem among certain patient populations and is highly prevalent in many urban areas. The responsibility for prescribing an appropriate drug regimen and ensuring that treatment is completed is assigned to the public health program or the clinician not to the patient. The initial prescribed regimen for the treatment of TB usually consists of 4 drugs: isoniazid, rifampin, pyrazinamide, and ethambutol. The minimum length for the treatment of drug-susceptible TB with a rifampin-based regimen is 6 to 9 months. Providing medications directly to the patient and watching him/her swallow the anti-TB drugs, which is termed directly observed therapy, is recommended for all patients diagnosed with TB and can help ensure higher completion rates, prevent the emergence of drug resistant TB, and enhance TB control. There has been renewed interest in the treatment of those with latent TB infection as a TB-control strategy in the United States for eliminating the large reservoir of individuals at risk for progression to TB. The 2 broad categories of persons who should be tested for latent TB infection are those who are likely to have been recently infected (such as contacts to infectious TB cases) and persons who are at increased risk of progression to TB disease following infection with Mycobacterium tuberculosis (eg, human immunodeficiency virus infection and selected medical conditions; recent immigrants to the United States from high TB-burden countries). The preferred regimen for the treatment of latent TB infection is 9 months of isoniazid. There is now renewed interest in and great need for the development of new drugs to treat TB and latent TB infection.
Similar articles
-
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.J Assoc Physicians India. 2006 Mar;54:219-34. J Assoc Physicians India. 2006. PMID: 16800350
-
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.MMWR Recomm Rep. 1998 Oct 30;47(RR-20):1-58. MMWR Recomm Rep. 1998. PMID: 9809743
-
Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.Clin Infect Dis. 2000 Jul;31(1):120-4. doi: 10.1086/313891. Epub 2000 Jul 25. Clin Infect Dis. 2000. PMID: 10913407 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Update on the treatment of tuberculosis.Am Fam Physician. 2008 Aug 15;78(4):457-65. Am Fam Physician. 2008. PMID: 18756652
Cited by
-
Substituted pyrazinecarboxamides: synthesis and biological evaluation.Molecules. 2006 Mar 29;11(4):242-56. doi: 10.3390/11040242. Molecules. 2006. PMID: 17962755 Free PMC article.
-
U.S. medical resident familiarity with national tuberculosis guidelines.BMC Infect Dis. 2007 Aug 2;7:89. doi: 10.1186/1471-2334-7-89. BMC Infect Dis. 2007. PMID: 17678548 Free PMC article.
-
Cough and fever in an immigrant adolescent with abnormal chest X-ray.Respir Med Case Rep. 2016 Oct 13;20:19-21. doi: 10.1016/j.rmcr.2016.10.010. eCollection 2017. Respir Med Case Rep. 2016. PMID: 27882294 Free PMC article.
-
Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.BMC Infect Dis. 2012 Jul 31;12:169. doi: 10.1186/1471-2334-12-169. BMC Infect Dis. 2012. PMID: 22849726 Free PMC article.
-
Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis.Int J Infect Dis. 2012 May;16(5):e391-6. doi: 10.1016/j.ijid.2011.12.018. Epub 2012 Mar 17. Int J Infect Dis. 2012. PMID: 22425494 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical